SCHEMBL9283236

SCHEMBL9283236

CCCc1cc(CCc2nc3c(Cl)ccc(Cl)c3o2)c(=O)[nH]c1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.41
HPGD P15428 4/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
GLA P06280 2/20 0.38
TSHR P16473 2/20 0.38
RAB9A P51151 2/20 0.37
NPC1 O15118 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2C19 P33261 1/20 0.37
MCL1 Q07820 1/20 0.37
HSD17B10 Q99714 2/20 0.36
PDE7B Q9NP56 1/20 0.33
KDM4E B2RXH2 4/20 0.32
MAPT P10636 4/20 0.32
APOBEC3A P31941 1/20 0.32
CTDSP1 Q9GZU7 1/20 0.32
APOBEC3G Q9HC16 1/20 0.32
GAA P10253 1/20 0.32
ELANE P08246 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9280809 0.93 ALDH1A1 (0.38) ALDH1A1HPGDMEN1KMT2AGLA
SCHEMBL9601892 0.81 ALDH1A1 (0.36) ALDH1A1HPGDMEN1KMT2AGLA
SCHEMBL9284917 0.81 ALDH1A1 (0.35) ALDH1A1HPGDMEN1KMT2AGLA
SCHEMBL9846224 0.78 PARP1 (0.37) ALDH1A1HPGDMEN1KMT2AGLA
SCHEMBL9846220 0.78 ALOX5 (0.32) ALDH1A1HPGDMEN1KMT2A
SCHEMBL9283877 0.77 ALDH1A1 (0.39) ALDH1A1HPGDMEN1KMT2AGLA
SCHEMBL9846155 0.75 MEN1 (0.31) ALDH1A1HPGDMEN1KMT2A
SCHEMBL9682811 0.75 HCAR2 (0.37) ALDH1A1HPGDMEN1KMT2AGLA
SCHEMBL9846101 0.75 ALDH1A1 (0.38) ALDH1A1HPGDMEN1KMT2AGLA
L-697661 SCHEMBL599639 0.75 FABP4 (0.34) ALDH1A1HPGDMEN1KMT2AGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0462800-A2 Inhibitors of HIV reverse transcriptase MERCK & CO. INC. (US) 1991-12-27 EP claimed
EP-0666744-A1 USE OF BHAP COMPOUNDS IN COMBINATION WITH OTHER NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS FOR THE TREATMENT OF HIV INFECTION THE UPJOHN COMPANY (US) 1995-08-16 EP disclosed
WO-1994009781-A1 USE OF BHAP COMPOUNDS IN COMBINATION WITH OTHER NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS FOR THE TREATMENT OF HIV INFECTION THE UPJOHN COMPANY (US) 1994-05-11 WO disclosed
EP-0462800-A2 Inhibitors of HIV reverse transcriptase MERCK & CO. INC. (US) 1991-12-27 EP disclosed